Lyell Immunopharma
LYEL
#8241
Rank
โ‚น15.20 B
Marketcap
โ‚น52.03
Share price
-4.41%
Change (1 day)
-70.49%
Change (1 year)

Lyell Immunopharma (LYEL) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น7.51 Billion

According to Lyell Immunopharma's latest financial reports the company's total liabilities are โ‚น7.51 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lyell Immunopharma - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น7.91 B-8.3%
2022-12-31โ‚น8.63 B-41.32%
2021-12-31โ‚น14.70 B5.94%
2020-12-31โ‚น13.88 B31.93%
2019-12-31โ‚น10.52 B